Domestic pharmaceutical market will open to Europe from July

Published: 2011-05-09 06:59:00

Updated: 2011-05-09 06:59:00

Starting July, pharmaceutical firms based in European Union member states will be able to sell their drugs at cheaper prices and expanding market share here, the Ministry of Justice said Thursday.

This is in line with the Korea-EU free trade agreement, which received parliamentary approval We...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK